In addition, they documented tumor deposition of C3 activation products and local increases in C3a and C5a, which induce maturation and activation of tumor-associated dendritic cells expressing the receptors for these anaphylatoxins and in turn promoting the anti-tumor activity of CD8+ T lymphocytes. This evidence concerns the gene CD8A and neoplasm.